Michel P. RATHBONE

Person

Ontario, CA

People

Patents Grantslast 30 patents

Information Patent Grant
Transformed cell lines expressing non-endogenous cell-surface selec...
- Patent number 10,520,491
- Issue date Dec 31, 2019
- LIBRAMEN NATURALS INC.
- Michel P. Rathbone
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
G-protein-coupled-receptor-22-transformed cell lines and methods of...
- Patent number 10,012,641
- Issue date Jul 3, 2018
- LIBRAMEN NATURALS INC.
- Michel P. Rathbone
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method of treating demyelinating diseases or conditions
- Patent number 7,534,803
- Issue date May 19, 2009
- Aventis Pharmaceuticals Inc.
- Craig P. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating of demyelinating diseases or conditions
- Patent number 6,967,210
- Issue date Nov 22, 2005
- Aventis Pharmaceuticals Inc.
- Craig P. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Carbon monoxide dependent guanylyl cyclase modifiers and methods of...
- Patent number 6,350,752
- Issue date Feb 26, 2002
- Alvin J. Glasky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Carbon monoxide dependent guanylyl cyclase modifiers and methods of...
- Patent number 5,801,184
- Issue date Sep 1, 1998
- Alvin J. Glasky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
G-PROTEIN COUPLED RECEPTOR 22 TRANSFORMED CELL LINES AND USES THEREFOR
- Publication number 20180335422
- Publication date Nov 22, 2018
- LIBRAMEN NATURALS INC.
- Michel P. RATHBONE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
G-PROTEIN COUPLED RECEPTOR 22 TRANSFORMED CELL LINES AND USES THEREFOR
- Publication number 20170115277
- Publication date Apr 27, 2017
- LIBRAMEN NATURALS INC.
- Michel P. RATHBONE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF ENTERIC GLIA
- Publication number 20110014694
- Publication date Jan 20, 2011
- NEUROLOGICAL TECHNOLOGIES INC.
- Shucui Jiang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATING OF DEMYELINATING DISEASES OR CONDITIONS
- Publication number 20090281147
- Publication date Nov 12, 2009
- Aventis Pharmaceuticals Inc.
- Craig P. SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATING OF DEMYELINATING DISEASES OR CONDITIONS
- Publication number 20090270458
- Publication date Oct 29, 2009
- Aventis Pharmaceuticals Inc.
- Craig P. SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATING OF DEMYELINATING DISEASES OR CONDITIONS
- Publication number 20090209594
- Publication date Aug 20, 2009
- Aventis Pharmaceuticals Inc.
- Craig P. SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATING OF DEMYELINATING DISEASES OR CONDITIONS
- Publication number 20090209595
- Publication date Aug 20, 2009
- Aventis Pharmaceuticals Inc.
- Craig P. SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of enteric glia to promote functional nerve connections
- Publication number 20060147425
- Publication date Jul 6, 2006
- Michel P Rathbone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Carbon monoxide dependent guanylyl cyclase modifiers and methods of...
- Publication number 20060063788
- Publication date Mar 23, 2006
- Spectrum Pharmaceuticals, Inc.
- Alvin J. Glasky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of treating demyelinating diseases or conditions
- Publication number 20060025452
- Publication date Feb 2, 2006
- Avenits Pharmaceuticals Inc.
- Craig P. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of treating of demyelinating diseases or conditions
- Publication number 20050234105
- Publication date Oct 20, 2005
- Aventis Pharmaceuticals Inc.
- Craig P. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of treating of demyelinating diseases or conditions
- Publication number 20040157889
- Publication date Aug 12, 2004
- Aventis Pharmaceuticals Inc.
- Craig P. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of treating of demyelinating diseases or conditions
- Publication number 20030105150
- Publication date Jun 5, 2003
- Craig P. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Carbon monoxide dependent guanylyl cyclase modifiers and methods of...
- Publication number 20020165242
- Publication date Nov 7, 2002
- Alvin J. Glasky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Michel P. RATHBONE

Person

Patents Grantslast 30 patents

Transformed cell lines expressing non-endogenous cell-surface selec...

G-protein-coupled-receptor-22-transformed cell lines and methods of...

Method of treating demyelinating diseases or conditions

Method of treating of demyelinating diseases or conditions

Carbon monoxide dependent guanylyl cyclase modifiers and methods of...

Carbon monoxide dependent guanylyl cyclase modifiers and methods of...

Patents Applicationslast 30 patents

G-PROTEIN COUPLED RECEPTOR 22 TRANSFORMED CELL LINES AND USES THEREFOR

G-PROTEIN COUPLED RECEPTOR 22 TRANSFORMED CELL LINES AND USES THEREFOR

USE OF ENTERIC GLIA

METHOD OF TREATING OF DEMYELINATING DISEASES OR CONDITIONS

METHOD OF TREATING OF DEMYELINATING DISEASES OR CONDITIONS

METHOD OF TREATING OF DEMYELINATING DISEASES OR CONDITIONS

METHOD OF TREATING OF DEMYELINATING DISEASES OR CONDITIONS

Use of enteric glia to promote functional nerve connections

Carbon monoxide dependent guanylyl cyclase modifiers and methods of...

Method of treating demyelinating diseases or conditions

Method of treating of demyelinating diseases or conditions

Method of treating of demyelinating diseases or conditions

Method of treating of demyelinating diseases or conditions

Carbon monoxide dependent guanylyl cyclase modifiers and methods of...